代谢综合征

       　代谢综合征是心血管疾病和糖尿病的主要危险因素，而心血管疾病和糖尿病都是严重威胁人类健康的疾病。代谢综合征出现在全美超过20％的成年人口中，这些人口患冠心病、中风等疾病的风险很高。对于心血管疾病而言，除了降低低密度脂蛋白外，有效地控制代谢综合征也是减少危险因素治疗的必要方法之一。代谢综合征和糖尿病被认为是冠心病的主要原因，对代谢综合征的治疗和管理为减少冠心病的危险因素提供了新的治疗和预防方向。为此CMBI特准备了代谢综合征的特别报道，供研究参考，更多文献请用相关关键词通过CMBI文献查询获取。

• Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-α in rats with sucrose-induced metabolic syndrome
  
• Pre-eclampsia and cardiovascular disease-metabolic syndrome of pregnancy
  
• Measures of Insulin Resistance Add Incremental Value to the Clinical Diagnosis of Metabolic Syndrome in Association With Coronary Atherosclerosis
  
• Prothrombotic markers in familial combined hyperlipidemia-Evidence of endothelial cell activation and relation to metabolic syndrome
  
• Fatty liver, hypertension, and the metabolic syndrome
  
• Homocysteine and reactive oxygen species in metabolic syndrome
  
• C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events
  
• Obesity, Metabolic Syndrome, and Cardiovascular Disease
  
• Adiponectin, Inflammation, and the Expression of the Metabolic Syndrome in Obese Individuals
  
• Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome
  
• Obesity and the Metabolic Syndrome in Children and Adolescents
  
• diabetes-Schizophrenia, the metabolic syndrome and diabetes
  
• Homocysteine and reactive oxygen species in metabolic syndrome
  
• Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk
  
• Relation to All-Cause and Cardiovascular Mortality
  
• Prognostic value of the metabolic syndrome in essential hypertension
  
• Angiotensin receptor blockadeimproves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome
  
• new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome
  
• Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome
  
• Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome
  
• Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with
  
• diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy
  
• clinical trials to reduce cardiovascular disease in patients with diabetes mellitus and insulin resistance
  
• metabolic syndrome
  
• Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men
  
• The metabolic syndrome and mortality from cardiovascular disease and all-causes
  
• Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease
  
• metabolic syndrome
  
• Structural equation model-based genome scan for the metabolic syndrome
  
• Phenotypic, genetic, and genome-wide structure in the metabolic syndrome
  
• A QTL genome scan of the metabolic syndrome and its component traits
  
• Hepatic Steatosis-A Mediator of the Metabolic Syndrome
  
• Manifestations of Metabolic Syndrome After Hypertensive Pregnancy
  
• Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease
  
• Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy
  
• The metabolic syndrome
  
• Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function
  
• Deleterious Impact of High Normal Glucose Levels and Other Metabolic Syndrome Components on Arterial Endothelial Function and Intima-Media
  
• Low-flow vascular remodeling in the metabolic syndrome X
  
• Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome
  
• Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome
  
• The metabolic syndrome and uric acid nephrolithiasis
  
• Metabolic Syndrome Modifies the Cardiovascular Risk Associated With Angiographic Coronary Artery Disease in Women
  
• Low-flow vascular remodeling in the metabolic syndrome X
  
• Adiponectin-and Metabolic Syndrome
  
• Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus
  
• Metabolic syndrome and type 2 diabetes mellitus-focus on PPAR
  
• Clinical Management of Metabolic Syndrome
  
• Definition of Metabolic Syndrome
  
• Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women
  
• Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke
  
• thiazolidinediones-Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus
  
• Metabolic Syndrome and Vascular Disease
  
• Adiponectin and Metabolic Syndrome
  
• Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients
  
• Recent Advances-Polyunsaturated Fatty Acid Regulation Of Gene Transcription-Molecular Mechanism To Improve Metabolic Syndrome
  
• Recent Advances-High-Insulinogenic Nutrition--An Etiologic Factor For Obesity And The Metabolic Syndrome
  
• Is Metabolic Syndrome-An Inflammatory Condition
  
• Diabetes-Shifting The Equilibrium From Activity To Food Leads To Autonomic Unbalance And The Metabolic Syndrome
  
• Kinetic Studies Of Lipoprotein Metabolism In The Metabolic Syndrome
  
• The Metabolic Syndrome-Peroxisome Proliferator-Activated Receptor And Its Therapeutic Modulation
  
• Emergence Of The Metabolic Syndrome With Menopause
  
• Metabolic Syndrome And Type-Diabetes Mellitus-Focus On Peroxisome Proliferator Activated Receptors (Ppar)
  
• Coronary Blood Flow Regulation In The Prediabetic Metabolic Syndrome
  
• Clinical Significance Of Cardiovascular Dysmetabolic Syndrome
  
• Prevalence And Profile Of Metabolic Syndrome In Patients Following Acute Coronary Events And Effects Of Therapeutic Lifestyle Change With Cardiac Rehabilitation
  
• Immunodeficiency Virus-Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome
  
• Cardiovascular Endocrinology-Emergence of the Metabolic Syndrome with Menopause
  
• hiv-Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome
  
• Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
  
• Clinical significance of cardiovascular dysmetabolic syndrome
  
• Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X
  
• Intimal Redox Stress-Accelerated atherosclerosis in metabolic syndrome
  
• C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
  
• Metabolic syndrome-major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation
  
• Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
  
• Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome
  
• Stress and the Metabolic Syndrome
  
• Adiponectin and resistin-New drug targets for type 2 diabetes and the metabolic syndrome
  
• Intrauterine Growth, the Vascular System, and the Metabolic Syndrome
  
• The role of 11b-hydroxysteroid dehydrogenase activity in the metabolic syndrome
  
• Obesity, Metabolic Syndrome, and Coronary Atherosclerosis
  
• Clinical significance of cardiovascular dysmetabolic syndrome
  
• Pathophysiology and Implications for Management of Cardiovascular Disease
  
• Intrauterine Growth, the Vascular System, and the Metabolic Syndrome
  
• Clinical significance of cardiovascular dysmetabolic syndrome
  
• Clinical significance of cardiovascular dysmetabolic syndrome
  
• Vascular Signaling Pathways in the Metabolic Syndrome
  
• The dysmetabolic syndrome
  
• Clinical significance of cardiovascular dysmetabolic syndrome
  
• New drug targets for type 2 diabetes and the metabolic syndrome
  
• Obesity, the metabolic syndrome, and cardiovascular disease
  
• Hypertension-Metabolic Syndrome and Related Cardiovascular Risk
  
• Hypertension-Adrenal and the Metabolic Syndrome
  
• Adipocyte metabolism and the metabolic syndrome
  
• Metabolic Abnormalities Characteristic of Dysmetabolic Syndrome Predict the Development of Transplant Coronary Artery Disease : A Prospective Study
  
• The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis